@inproceedings{inproceedings, title  = {{Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial}},

 url = {{}},

 year = {{2023}},

 month = {{1}},

 author = {{Paller A and Siegfried E and Sidbury R and Lockshin B and Cork M and Pinter A and Xiao J and Stanton S and Khokhar F and Bansal A and Prescilla R}},

 volume = {{89}},

 journal = {{JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{AB100-AB100}},

 note = {{Accessed on 2024/12/22}}}